about
Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interactionExosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatinEpigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.Prognostic biomarkers in ovarian cancer.Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancersGene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicinAn apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancerFucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells.Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.ERCC1: impact in multimodality treatment of upper gastrointestinal cancer.Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.Developing central nervous system and vulnerability to platinum compounds.Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats.The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
P2860
Q28484387-1C1F0A1D-2689-4BA2-AE31-C4D32BF9644CQ28539631-4F8CF0D6-A338-4B40-9EF4-E4CCB1055DE2Q33572313-53E4E02B-6C13-46D8-89D2-E85EF3AFB925Q33750182-823034CC-9BF6-4741-BC3E-1EDF54152504Q34086636-7AE60FAC-2C10-47BB-80E9-D87C335266D0Q34408036-477E34C3-1A9E-4361-AAC3-34C292931C4DQ34435134-C2C83B7B-B74D-4D13-8756-49EDB53E26A2Q35674891-12550FCF-B599-4E82-8DD8-1C0D733A386FQ35941858-4BF6295E-C650-4781-BDD0-1AEC79AEE171Q36262399-68F23FA0-4F68-4549-A827-C8280A7EC226Q36510958-66A417C8-2C41-43C2-87F2-61A9586B1A72Q36586981-7642AE71-BF14-4384-A272-A4D711DF6A1FQ36790826-59F5C891-D8D8-4F9F-B0EF-B52E960EB001Q37275739-ED8D9E3A-8002-4F25-BD96-82BAE7354674Q37323073-D9337367-9640-49C1-8E18-345FF142E99FQ37818224-A2842244-C429-451F-842A-823D58084A55Q39458583-68F7F057-20B9-462C-8819-75A271BDA538Q40631758-61FD87BE-18E7-4DC8-8536-19D50F1CCE88Q40955139-438539E4-B27F-45DC-9A02-E4A31AF9C904Q42708068-721A69DA-BF49-43DD-9F34-2573D0FAE608Q54330349-32F928D2-0E73-4E2A-826C-48F7D4C4801CQ57500237-810EED20-4E48-4C8B-91D0-A1FDF8F1CE55
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel strategies for reversing platinum resistance.
@en
Novel strategies for reversing platinum resistance.
@nl
type
label
Novel strategies for reversing platinum resistance.
@en
Novel strategies for reversing platinum resistance.
@nl
prefLabel
Novel strategies for reversing platinum resistance.
@en
Novel strategies for reversing platinum resistance.
@nl
P2093
P2860
P1476
Novel strategies for reversing platinum resistance.
@en
P2093
Anil K Sood
Gabriel Lopez-Berestein
Mian M K Shahzad
P2860
P304
P356
10.1016/J.DRUP.2009.09.001
P577
2009-10-04T00:00:00Z